Thus, the direct or indirect action of pitavastatin on the phosphatidylethanolamine N-methyltransferase pathway may contribute to its overall effect on the plasma lipidome in prediabetes and insulin resistance, with potential for either a neutral or attenuating effect on risk of development of T2D. The gene discussed is PEMT; the disease is prediabetes syndrome.